Incidentally find an adrenal tumor on health screening by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

Slides:



Advertisements
Similar presentations
The Thyroid Incidentaloma
Advertisements

CORE Case 2 Workshop Petra Lewis MD Professor of Radiology and OBGYN
ROLE OF FDG-PET/CT STUDY IN THE DETECTION OF BONE MARROW DISEASE IN PATIENTS WITH AGGRESSIVE NON- HODGKIN LYMPHOMA (NHL) AND HODGKIN LYMPHOMA (HL) Figure.
18F- FDG PET/CT in the Diagnosis of Tumor Thrombosis
Dr. LP Si Yan Chai Hospital. Background With the increasing use of imaging modalities, more and more clinically inconspicuous thyroid lesions are discovered.
Update in the Management of Thyroid Neoplasms University of Washington
Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.
JHSGR 16 th April 2011 Dr Lee Man Kit Derek.  The value of PET in staging adenocarcinoma (e.g. colorectal cancer) is well established Tomoharu T. et.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Approach.
Breast Imaging Made Brief and Simple
Case Report # 1 Submitted By: Samuel Oats, MSIV Radiological Category: Body Principal Modality (1): Principal Modality (2): PET/CT CT Faculty Reviewer:
Dual-time point 18F-FDG PET/CT scan: is it always working?
Functional Imaging with PET for Sarcoma Rodney Hicks, MD, FRACP Director, Centre for Molecular Imaging Guy Toner, MD, FRACP Director, Medical Oncology.
Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.
18 FDG PET/CT in the diagnosis of Malignant Peripheral Nerve Sheath Tumours VS Warbey, RE Ferner, JT Dunn, E Calonje, MJ O’Doherty St Thomas’ Clinical.
Progress report High sensitivity and low cost human PET system: viability tests POCI/SAU-OBS/61642/2004 J. J. Pedroso de Lima.
Rare mammary gland diseases: a continuous challenge for the clinician
ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 10/2/09.
ACRIN 6685 Overview ACRIN 6685 A Multi-center Trial of FDG-PET/CT Staging of Head and Neck Cancer and its Impact on the N0 Neck Surgical Treatment in Head.
Follow up in Chest Tumors : Value of integrated PET/CT By : Dr. Heba Nabil, MSc Radiology Specialist at Nasser Institute For Research and Treatment.
CASEFINDING Debra W. Christie, MBA, RHIA, CTR, CCRP Director, Cancer Research & Data Center University of Mississippi Medical Center.
11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,
Early detection of a colon cancer on health screening by PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.
Unexpected additional lung cancer in a patient with already known inflammatory myofibroblastic tumor detected on PET/CT Kaohsiung Veterans General Hospital.
Early detection of an endometrial cancer on health screening by PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.
ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 9/30/10.
Endocrine Post Clinic Conference September 2, yo man with hypertension.
Monitoring the radioimmunotherapeutic effect by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.
FDG PET/CT case report early detection of ovarian cancer NM case conference, chairman: Nan-Jing Peng, MD.
Evaluation of Thyroid Nodules
WELCOME. PET/CT CASE REVIEW COURSE JANUARY 31 ST PASADENA CONVENTION CENTER LOS ANGELES RADIOLOGIC SOCIETY MID WINTER MEETING.
CARATTERIZZAZIONE DI LESIONI DI ORIGINE SCONOSCIUTA SOSPETTE PER LESIONI MALIGNE NEI PAZIENTI PEDIATRICI: POSSIBILE RUOLO DEL 18F-FDG PET/CT A.Cistaro.
ACRIN 6682 Phase II Trial OF 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 10/4/08.
Albert J. Chang, MD, PhD 1 Farrokh Dehdashti, MD 2 Perry W. Grigsby, MD, MS 1 Department of Radiation Oncology 1 Department of Radiology and Nuclear Medicine.
Unexpected additional thyroid cancer in a patient with already known cervical cancer detected on PET/CT Kaohsiung Veterans General Hospital Kuan-Hsiu Lin,
Educational case 1 Dr JD Hemming Queen Elizabeth Hospital Gateshead.
Thyroid Uptake on FDG PET/CT: What the Radiologist Needs to Know
3 STUDENT ASSESSMENT DEPARTMENT
간담도 암에서의 PET 의 활용 핵의학과 홍일기. 18 F-FDG PET: Warburg effect.
Background: Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a complex growth pattern. Imaging plays a crucial role in diagnosis.
CHONBUK NATIONAL UNIVERSITY HOSPITAL Great Day to you! CHON BUK NATIO NAL UNIVE RSITY HOSPI TAL GIM BYUNG CHUL The Change on PET/CT Image of Patients with.
Fig. 9. Warthin's tumor, a 72-year-old man with supraglottic cancer. A
Fig. 2. Arterial fluorodeoxyglucose (FDG) uptake related to atherosclerosis. On positron emission tomography (PET) coronal (A), PET/CT fusion coronal (B),
Pulmonary artery stent infection
CT and PET imaging in non-small cell lung cancer
Incidental significant finding on FDG-PET/CT
Evaluation of Incidental Thyroid Nodules in Cancer Patients
Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related.
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Predictive Value of 18F-FDG PET/CT in Patients with.
FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.
Figure 1 Carotid artery inflammation detected using 18F-FDG-PET
Gingival Metastasis as First Sign of Multiorgan Dissemination of Epithelioid Malignant Mesothelioma  Andrea Billè, Marco Platania, Giuseppe Pelosi, Barbara.
علم الكائنات الحية المجهرية
Positron Emission Tomography in Lung Cancer
Bilateral Adrenal Adenomas and Persistent Leukocytosis: A Unique Case of Cushing’s Syndrome  Nilay Desai, MD, Anoop Kapoor, MD, Binod K. Singh, MD, Jingxuan.
Future of Thoracic PET Scanning
Case Study 37 Henry Armah, M.D., M.Phil..
Future of Thoracic PET Scanning
Adult Female With Malignant Pain
Are We Missing Diagnosis of Large Vessel Vasculitis
Maximum Standardized Uptake Value on FDG-PET Is a Strong Predictor of Overall and Disease-Free Survival for Non–Small-Cell Lung Cancer Patients after.
SUMMARY OF ADRENAL IMAGING
Metabolic PHENOTYPE by NMR spectroscopy: A biomarker for lung CANCER
High SUVmax on FDG-PET Indicates Pleomorphic Subtype in Epithelioid Malignant Pleural Mesothelioma: Supportive Evidence to Reclassify Pleomorphic as Nonepithelioid.
Value of Combined Interpretation of Computed Tomography Response and Positron Emission Tomography Response for Prediction of Prognosis After Neoadjuvant.
Detection of an Asymptomatic Right-Ventricle Cardiac Metastasis from a Small-Cell Lung Cancer by F-18-FDG PET/CT  Maria Victoria Orcurto, MD, Angelika.
Resection of a Solitary Pulmonary Metastasis from Prostatic Adenocarcinoma Misdiagnosed as a Bronchocele: Usefulness of 18F-Choline and 18F-FDG PET/CT 
Evaluation of Average CT to reduce the artifact in PET/CT
Fig. 5. A 62-year-old woman with mixed invasive ductal and mucinous cancer involving left breast underwent breast MRI and PET-CT. (a) On axial breast MRI,
Figure 12a Pitfalls in N staging at CT and PET
Presentation transcript:

Incidentally find an adrenal tumor on health screening by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine

 Abstract: Whole-body FDG-PET has been used to screen underlying malignancy of health people for decades. Recently, PET/CT has been advocated as a tool for improvement of diagnosis by FDG- PET. We assessed the PET/CT results of asymptomatic individuals for health screening in our PET center. The final confirmation of cancer was based on pathologic report. Here, a case of benign adrenal tumor was presented.

SUVmax: 4.3  3.3 Pathology: Conn’s disease 57 y/o female A 1.2 cm well- defined low- density nodule with increased FDG uptake in right adrenal gland (HUmean <5 ). Figure 1